Product Information
CLONAZEPAM 1 MG TABLET is a generic product labeled by AvPAK, priced at $0.0245 per EA under NDC 50268017415. Its NADAC has been published 158 times since Aug 16, 2023.
FDA first approved this application on Jun 28, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
AvPAKNDC
50268017415
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856FDA Approved
6/28/2006
TE Code
AB
On Market Since
1/16/2023
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG TABLET has been published 158 times since Aug 16, 2023, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0245 per EA |
|---|---|
| All-time high | $0.0342 (Sep 13, 2023) |
| All-time low | $0.0244 (Jul 22, 2026) |
| 52-week high | $0.0300 |
| 52-week low | $0.0244 |
| Median price | $0.0292 |
| Average price | $0.0288 |
| Largest weekly change | +23.6% (Jun 19, 2024) |
| Weeks tracked | 158 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG TABLET, manufactured by AvPAK, is $0.0245 per EA (NDC 50268017415), effective Aug 19, 2026.
How has the price of CLONAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG TABLET has declined 23.7%. It has been tracked across 158 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG TABLET?
Since Aug 16, 2023, the NADAC for CLONAZEPAM 1 MG TABLET has ranged from a low of $0.0244 (Jul 22, 2026) to a high of $0.0342 (Sep 13, 2023), with a median of $0.0292 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 1 MG TABLET?
CLONAZEPAM 1 MG TABLET (NDC 50268017415) is labeled by AvPAK, and CMS classifies it as a generic product.